Search for Terms or Answers
While decades of drug development have improved treatment options, some of our older drugs are harder to improve upon. The same can be said for old movies and new movies, or classic literature and current best sellers. Which do you prefer or rely on?
I have a 21 yr. old lupus nephritis patient on mycophenolate, hydroxychloroquine and prednisone 40 mg per day. She says both her current nephrologist and her prior pediatric rheumatologist told her NOT to get pneumococcal and flu vaccines. I thought she is supposed to get them - any comment?
Discussions on drug safety can be as treacherous as quicksand for the patient and physician. What the physician knows and what the patient perceives may not be in sync.
Today marks the one year anniversary of hydrocodone becoming a schedule II drug with more restrictive access. Has life been better under these new rules?
RA patient complicated by invasive fungal infection with coccidioidomycosis is discussed by Drs. Tesser and Cush
Is off-label drug use an example of "free speech"? Do off-label use guidelines affect every day practice or the way Pharma promotes its product outside of the indications for which it was approved?
Rheumatoid arthritis affects women in their child-bearing years and many will face the issue of pregnancy and RA management at some point. Here are11 considerations for those managing RA patients who wish to become pregnant.
Travel can be challenging for arthritis patients. Here are some useful tips to travel smoothly and pain free.
The prevention of Herpes zoster infections can be challenging in patients receiving immunosuppressives or biologic therapies. Dr. Artie Kavanugh reviews a new, potential advance in vaccination for shingles.
Comorbidities often influence the choice of therapies in RA. This elderly man with hepatitis and TB needs aggressive treatment, but what drugs can reasonably be considered?
Inefficient peer-to-peer physician communication has eroded integrated care and compromised patient outcomes and safety. Picking up the smart phone and use of technology may help to close these gaps.
Drug efficacy is swiftly proven in phase II and III trials. Yet drug safety requires time, wider exposure, physician education and patient acceptance to be fully established.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
